share_log

Piper Sandler Maintains Overweight on Aptose Biosciences, Maintains $5 Price Target

Moomoo 24/7 ·  Apr 3 11:58

Piper Sandler analyst Edward Tenthoff maintains Aptose Biosciences (NASDAQ:APTO) with a Overweight and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment